View Item 

Show simple item record

The Risk of Cancer for Patients on Dialysis: A Review
dc.contributor.authorRagheb, Nawal E.en_US
dc.contributor.authorPort, Friedrich K.en_US
dc.contributor.authorSchwartz, Ann Grossbarten_US
dc.date.accessioned2010-06-01T19:10:08Z
dc.date.available2010-06-01T19:10:08Z
dc.date.issued1991-10en_US
dc.identifier.citationRagheb, Nawal E.; Port, Friedrich K.; Schwartz, Ann Grossbart (1991). "The Risk of Cancer for Patients on Dialysis: A Review." Seminars in Dialysis 4(4): 253-257. <http://hdl.handle.net/2027.42/72354>en_US
dc.identifier.issn0894-0959en_US
dc.identifier.issn1525-139Xen_US
dc.identifier.urihttps://hdl.handle.net/2027.42/72354
dc.format.extent591122 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights1991 Blackwell Publishing Ltd.en_US
dc.titleThe Risk of Cancer for Patients on Dialysis: A Reviewen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumFrom the Michigan State University, College of Human Medicine, East Lansing (NER), the University of Michigan, Departments of Internal Medicine and Epidemiology, and the Michigan Kidney Registry, Ann Arbor (FKP), and the Michigan Cancer Foundation, Division of Epidemiology, Detroit (AGS), Michiganen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/72354/1/j.1525-139X.1991.tb00104.x.pdf
dc.identifier.doi10.1111/j.1525-139X.1991.tb00104.xen_US
dc.identifier.sourceSeminars in Dialysisen_US
dc.identifier.citedreferencePenn I: Malignant lymphomas in organ transplant recipients. Transplant Proc 13: 736 – 738, 1981.en_US
dc.identifier.citedreferenceStarzl TE, Penn I, Putnam CW, et al.: Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy. Transplant Rev 7: 112 – 145, 1971.en_US
dc.identifier.citedreferencePenn I, Starzl TE: Malignant tumors arising de novo in immunosuppressed organ transplant recipients. Transplantation 14: 407 – 417, 1972.en_US
dc.identifier.citedreferenceHoover R, Fraumeni JF: Risk of cancer in renal-transplant recipients. Lancet 2: 55 – 57, 1973.en_US
dc.identifier.citedreferenceMatas AJ, Simmons RL, Kjellstrand CM, et al.: Increased incidence of malignancy during chronic renal failure. Lancet 1: 883 – 885, 1975.en_US
dc.identifier.citedreferenceMiach PJ, Dawborn JK, Xipell J: Neoplasia in patients with chronic renal failure on long-term dialysis. Clin Nephrol 5: 101 – 104, 1976.en_US
dc.identifier.citedreferenceSlifkin RF, Goldberg J, Neff MS, et al.: Malignancy in end stage renal disease. Trans Am Soc Artif Intern Organs 23: 34 – 39, 1977.en_US
dc.identifier.citedreferenceSutherland GA, Glass J, Gabriel R: Increased incidence of malignancy in chronic renal failure. Nephron 18: 182 – 184, 1977.en_US
dc.identifier.citedreferenceHerr HW, Engen DE, Hosteller J: Malignancy in uremia: Dialysis versus transplantation. J Urol 121: 584 – 586, 1979.en_US
dc.identifier.citedreferenceKinlen LJ, Eastwood JB, Kerr DN, et al.: Cancer in patients receiving dialysis. Br Med J 1: 1401 – 1403, 1980.en_US
dc.identifier.citedreferenceJacobs C, Brunner FP, Brynger H, et al.: Malignant diseases in patients treated by dialysis and transplantation in Europe. Transplant Proc 13: 729 – 732, 1981.en_US
dc.identifier.citedreferenceSheil AGR, Flavel S, Disney APS, et al.: Cancer development in patients progressing to dialysis and renal transplantation. Transplant Proc 17: 1685 – 1688, 1985.en_US
dc.identifier.citedreferenceOta K, Yamashita N, Suzuki T, et al.: Malignant tumors in dialysis patients: A nationwide survey. Proc Eur Dial Transplant Assoc 18: 724 – 730, 1981.en_US
dc.identifier.citedreferenceIshikawa I, Saito Y, Naoto S, et al.: Ten-year prospective study on the development of renal cell carcinoma in dialysis patients. Am J Kidney Dis 16: 452 – 458, 1990.en_US
dc.identifier.citedreferenceO'Shea ES, Molina AM, Frau JF, et al.: Cancer de vejiga y hemodialisis. Arch Esp Urol 43: 359 – 363, 1990.en_US
dc.identifier.citedreferenceBush A, Gabriel R: Cancer in uremic patients. Clin Nephrol 22: 77 – 81, 1984.en_US
dc.identifier.citedreferenceDigenis GE, Pierratos A, Ayiomamitis A, et al.: Cancer in patients on CAPD. Peritoneal Dial Bull 6: 122 – 124, 1986.en_US
dc.identifier.citedreferenceKircher T, Anderson RE: Cause of death: Proper completion of the death certificate. JAMA 258: 349 – 352, 1987.en_US
dc.identifier.citedreferencePercy C, Stanek E, Gloeckler L: Accuracy of cancer death certificates and its effects on cancer mortality statistics. Am J Public Health 71: 242 – 250, 1981.en_US
dc.identifier.citedreferenceYoung JL, Percy C, Asire A, ( eds ): Surveillance, Epidemiology, and End Results: Incidence and Mortality Data, 1973–1977 ( National Cancer Institute Monograph No. 57 ), 1981.en_US
dc.identifier.citedreferenceKantor AF, Hoover RN, Kinlen LJ, et al.: Cancer in patients receiving long-term dialysis treatment. Am J Epidemiol 126: 370 – 376, 1987.en_US
dc.identifier.citedreferencePort FK, Ragheb NE, Schwartz AG, et al.: Neoplasms in dialysis patients: A population-based study. Am J Kidney Dis 14: 119 – 123, 1989.en_US
dc.identifier.citedreferenceLindner A, Farewell VT, Sherrard DJ: High incidence of neoplasia in uremic patients receiving long-term dialysis. Nephron 27: 292 – 296, 1981.en_US
dc.identifier.citedreferenceGoldblum SE, Reed WP: Host defenses and immunologic alterations associated with chronic hemodialysis. Ann Intern Med 93: 597 – 613, 1980.en_US
dc.identifier.citedreferenceSoubrane C, Jacobs C, Jacquillat C, et al.: Influence of the uremic state on the development of malignancy. Am J Nephrol 6: 363 – 368, 1986.en_US
dc.identifier.citedreferenceNewsom GD, Vugrin D: Etiologic factors in renal cell adenocarcinoma. Semin Nephrol 7: 109 – 116, 1987.en_US
dc.identifier.citedreferenceBommer J, Ritz E: Water quality: A neglected problem in hemodialysis. Nephron 46: 1 – 6, 1987.en_US
dc.identifier.citedreferenceYanagisawa H, Manabe S, Kanai Y, et al.: Carcinogenic glutamic acid pyrolysis product in the dialysate of uremic patients treated by continuous ambulatory peritoneal dialysis. Clin Nephrol 30: 73 – 78, 1988.en_US
dc.identifier.citedreferenceBommer J, Ritz E: Ethylene oxide as a major cause of anaphylactoid reactions in dialysis: A review. Int J Artif Organs 11: 111 – 117, 1987.en_US
dc.identifier.citedreferenceSwanson GM: Cancer prevention in the workplace and natural environment, a review of etiology, research design, and methods of risk reduction. Cancer 62: 1725 – 1746, 1988.en_US
dc.identifier.citedreferenceBommer J, Ritz E, Andrassy K: Side effects due to materials used in hemodialysis equipment. Adv Nephrol 14: 409 – 438, 1984.en_US
dc.identifier.citedreferencePateras VR: Malignancy in chronic dialysis patients. Int J Artif Organs 8: 301 – 302, 1985.en_US
dc.identifier.citedreferenceWing AJ, Jacobs C, Selwood NH: Cancer and patients with end-stage renal failure (Letter). Br Med J 284: 504, 1982.en_US
dc.identifier.citedreferenceAjam M, Ramanujam LS, Gandhi VC, et al.: Colon-cancer screening in dialysis patients. Artif Organs 14: 95 – 97, 1990.en_US
dc.identifier.citedreferenceSteenland NK, Thun MJ, Ferguson WS, et al.: Occupational and other exposures associated with male end-stage renal disease: A case-control study. Am J Public Health 80: 153 – 157, 1990.en_US
dc.identifier.citedreferenceNelson NA, Robins TG, Port FK: Solvent nephrotoxicity in humans and experimental animals. Am J Nephrol 10: 10 – 20, 1990.en_US
dc.identifier.citedreferenceBengtsson U, Johansson S, Angervall L: Malignancies of the urinary tract and their relation to analgesic abuse. Kidney Int 13: 107 – 113, 1978.en_US
dc.identifier.citedreferenceTaylor JS: Carcinoma of the urinary tract and analgesic abuse. Med J Aust 1: 407 – 409, 1972.en_US
dc.identifier.citedreferenceDunnill MS, Millard PR, Oliver D: Acquired cystic disease of the kidneys: A hazard of long-term intermittent maintenance haemodialysis. J Clin Pathol 30: 868 – 877, 1977.en_US
dc.identifier.citedreferenceMirahmadi MK, Vaziri ND: Cystic transformation of end-stage kidneys in patients undergoing hemodialysis. Int J Artif Organs 3: 267 – 270, 1980.en_US
dc.identifier.citedreferenceGrantham JJ, Levine E: Acquired cystic disease: Replacing one kidney disease with another. Kidney Int 28: 99 – 105, 1985.en_US
dc.identifier.citedreferenceHughson MD, Buchwald D, Fox M: Renal neoplasia and acquired cystic kidney disease in patients receiving long-term dialysis. Arch Pathol Lab Med 110: 592 – 601, 1986.en_US
dc.identifier.citedreferenceBretan PN, Busch MP, Hricak H, et al.: Chronic renal failure: A significant risk factor in the development of acquired renal cysts and renal cell carcinoma. Cancer 57: 1871 – 1879, 1986.en_US
dc.identifier.citedreferenceNoronha IL, Ritz E, Waldherr R, et al.: Renal cell carcinoma in dialysis patients with acquired renal cysts. Nephrol Dial Transplant 4: 763 – 769, 1989.en_US
dc.identifier.citedreferenceJabour BA, Ralls PW, Tang WW, et al.: Acquired cystic disease of the kidneys: Computed tomography and ultrasonography appraisal in patients on peritoneal and hemodialysis. Invest Radiol 22: 728 – 732, 1987.en_US
dc.identifier.citedreferenceLevine E, Grantham JJ, Slusher SL, et al.: CT of acquired cystic kidney disease and renal tumors in long-term dialysis patients. Urol Radiol 6: 153 – 157, 1984.en_US
dc.identifier.citedreferencePenn I: Tumors of the immunocompromised patient. Annu Rev Med 39: 63 – 73, 1988.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1525-139X.1991.tb00104.x.pdf
Size:
577.2KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.